C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 239/08 (2006.01) A61K 31/16 (2006.01) A61K 31/40 (2006.01) A61K 31/505 (2006.01) A61K 38/05 (2006.01) C07C 237/22 (2006.01) C07C 259/06 (2006.01) C07D 207/408 (2006.01) C07D 209/48 (2006.01) C07D 211/88 (2006.01) C07D 233/72 (2006.01) C07D 233/74 (2006.01) C07D 239/54 (2006.01) C07K 5/06 (2006.01) C07K 5/062 (2006.01) C07K 5/065 (2006.01) C07K 5/068 (2006.01)
Patent
CA 2098166
RAN 4070/086 Abstract The invention provides hydroxamic acid derivatives of the formula Image (I) wherein R1 represents 1-7C alkyl; R2 represents hydrogen, 1-6C alkyl or a group of the formula -(CH2)n-aryl or -(CH2)n-Het in which n stands for 1-4 and Het represents a 5- or 6-membered N-heterocyclic ring which (a) is attached via the N atom, (b) optionally contains N, O and/or S as additional hetero atom(s) in a position or positions other than adjacent to the linking N atom, (c) is substituted by oxo on one or both C atoms adjacent to the linking N atom and (d) is optionally benz-fused or option- ally substituted on one or more other carbon atoms by 1-6C alkyl or oxo and/or on any additional N atom(s) by 1-6C alkyl; R3 represents the characterizing group of a natural or non-natural .alpha.-amino acid in which any functional group present may be protected, with the proviso that R3 does not represent hydrogen; R4 represents carboxyl, (1-6C alkoxy)- carbonyl, carbamoyl or (1-6C alkyl)carbamoyl; R5 represents the characterizing group of a naturally occurring .alpha.-amino acid in which any functional group present may be protected; and R6 represents hydrogen; or R4, R5 and R6 each individually represent hydrogen or 1-6C alkyl, and their pharmaceutically acceptable salts, which are matrix metalloproteinase inhibitors useful for the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteo- arthritis or for the treatment of invasive tumours, atherosclerosis or multiple sclerosis. They can be manufactured according to generally known methods by deprotecting a corresponding novel benzyloxyamino compound or hydroxamidating a corresponding novel amino acid or activated derivative thereof.
Broadhurst Michael John
Brown Paul Anthony
Johnson William Henry
Lawton Geoffrey
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Hydroxamic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1697915